Abstract
Novel C4-benzazole naphthalimide derivatives were synthesized and tested in vitro and in vivo as anti-cancer drugs. Among these synthetic molecules, compounds 9 and 10 exhibited cytotoxicity against murine B16F10 melanoma cells. In addition, the above-mentioned compounds significantly suppressed lung tumor metastasis with no visible sign of toxicity.
Keywords:
B16F10 cells; Benzazole; MTS assay; Melanoma; Naphthalimide; Topoisomerase II.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antineoplastic Agents / chemical synthesis*
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacology*
-
Cell Line, Tumor
-
Cell Proliferation / drug effects
-
Cell Survival / drug effects
-
DNA Topoisomerases, Type II / metabolism
-
Dose-Response Relationship, Drug
-
Drug Screening Assays, Antitumor
-
Female
-
Melanoma / drug therapy*
-
Melanoma / metabolism
-
Melanoma / pathology
-
Mice
-
Mice, Inbred C57BL
-
Molecular Structure
-
Naphthalimides / chemical synthesis
-
Naphthalimides / chemistry
-
Naphthalimides / pharmacology*
-
Structure-Activity Relationship
-
Topoisomerase II Inhibitors / chemical synthesis
-
Topoisomerase II Inhibitors / chemistry
-
Topoisomerase II Inhibitors / pharmacology*
Substances
-
Antineoplastic Agents
-
Naphthalimides
-
Topoisomerase II Inhibitors
-
DNA Topoisomerases, Type II